EFPIA - NEWSLETTER

EFPIA Newsletter 23 July 2026

News

23 July 2026 EFPIA submission to the EU Biotech Act consultation

EFPIA welcomes the European Commission's initiative to develop the Biotech Act and strongly supports its objective of...

EFPIA Rentrée 2026

Join us on 7 September for the annual EFPIA Rentrée, marking the start of the new policy season. Bringing together EFPIA members, colleagues and partners, the reception provides an opportunity to reconnect after the summer break, exchange perspectives on the months ahead, and continue the conversations that will shape our work throughout the rest of the year.

Event details:

Monday, 7 September 2026
18:30–20:30 CEST
Residence Palace, Rue de la Loi 155, Brussels

Register here by 21 August.

Europe’s Choice: The value of investing in innovation

If you were unable to join our Conference in person, you can find the recordings here.

Joint interview "What makes innovators choose Europe?"

Panel 1- Waking up in a new World Disorder: How to be open to trade, while protecting key industries

Events

21 SEP 2026

World Bladder Cancer Patient Forum 2026 Hong Kong and Online

Taking place in Hong Kong this September, the event is also open to remote participants.

Learn more →

14 OCT 2026

From medicines shortages to medicines security: Building a more resilient European... Brussels, Belgium

Bringing together stakeholders from across the healthcare value chain, this HCI event will explore how Europe can strengthen...

Learn more →

What we are reading

Europe treats new medicines as a cost. The evidence says they’re an investment. 16 July 2026 (Johnson & Johnson)

Dutch innovative pharma adding €8.5 billion to economy 15 July 2026 (Euractiv)

Nordic initiative signals new approach to tackling drug resistance 06 July 2026 (Euractiv)

Global regulations governing orphan drug designation 01 July 2026 (RAPS)

Eight vaccines linked to a lower risk of dementia 28 April 2026 (Gavi)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶